Open access
Open access
Powered by Google Translator Translator

Study: Fewer than 10% of people in the US had detectable SARS-CoV-2 antibodies as of September 2020

30 Nov, 2020 | 01:00h | UTC

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 – JAMA Internal Medicine

Commentaries: Less than 10% of Americans had COVID by September, study finds – CIDRAP AND Antibodies, Immunity, and COVID-19 – JAMA Internal Medicine AND Covid-19: Nationwide SARS-CoV-2 Seroprevalence Remains Low – Physician’s Weekly

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.